Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: Impact on ischaemia-reperfusion injury and clinical relevance

HPB

Volumn 12, Issue 7, 2010, Pages 439-446

  Andreani, Paola ^a   Hoti, Emir ^a   De La Serna, Sofia ^a   Esposti, Davide Degli ^b   Sebagh, Mylène ^c   Lemoine, Antoinette ^b   Ichai, Philippe ^a   Saliba, Fauzi ^a   Castaing, Denis ^a   Azoulay, Daniel ^a,c  

^a IFR 899   (France)

^b Département de Biochimie et Biologie Moléculaire   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Graft ischemic preconditioning; LRLT

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; METHYLPREDNISOLONE; PROTHROMBIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY THROMBOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT INJURY; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLD ISCHEMIA; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEMOPERITONEUM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; LENGTH OF STAY; LIVER; LIVER CANCER; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; LIVING RELATED RIGHT LOBE LIVER TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; PROTHROMBIN TIME; REOPERATION; REPERFUSION INJURY; RISK FACTOR; TREATMENT OUTCOME;

EID: 77956918962     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00194.x     Document Type: Article

References (56)

1. Yamaoka Y, Washida M, Honda K, Tanaka K, Mori K, Shimahara Y et al. (1994) Liver transplantation using a right lobe graft from a living related donor. Transplantation 57:1127-1130.
2. Todo S, Furukawa H, Jin MB et al. (2000) Living donor liver transplantation in adults: Outcome in Japan. Liver Transpl 6:S66-S72.
3. Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE et al. (2003) A survey of liver transplantation from living adult donors in the United States. N Engl J Med 348:818-825.
4. Everhart JE, Lombardero M, Detre KM et al. (1997) Increased waiting time for liver transplantation results in higher mortality. Transplantation 64:1300-1306.
5. Sarasin FP, Majno PE, Llovet JM et al. (2001) Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology 33:1073-1079.
6. Cheng SJ, Pratt DS, Freeman RB Jr et al. (2001) Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis. Transplantation 72:861-868.
7. Marcos A. (2000) Right lobe living donor liver transplantation: A review. Liver Transpl 6:3-20.
8. Murry CE, Jennings RB, Reimer KA. (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124.
9. Carini R, Albano E. (2003) Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125:1480-1491.
10. Jaeschke H. (2003) Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284:G15-G26. (Pubitemid 36076246)
11. Pang CY, Yang RZ, Zhong A et al. (1995) Acute ischemia preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 29:782-788.
12. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. (1997) Mechanisms of ischemic preconditioning. Shock 8:86-94.
13. Bonventre JV. (2002) Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11:43-48.
14. Kirino T. (2002) Ischemic tolerance. J Cereb Blood Flow Metab 22:1283-1296.
15. Du ZY, Hicks M, Winlaw D et al. (1996) Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant 15:1258-1267.
16. Serracino-Inglott F, Habib NA, Mathie RT. (2001) Hepatic-ischemia reperfusion injury. Am J Surg 181:160-166.
17. Selzner N, Rüdiger H, Graf R, Clavien PA. (2003) Protective strategies against ischemic injury of the liver. Gastroenterology 125:917-936.
18. Clavien PA, Yadav S, Sindram D, Bentley RC. (2000) Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232:155-162.
19. Clavien PA, Selzner M, Rüdiger HA et al. (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238:843-852.
20. Nuzzo G, Giugliante F, Vellone M et al. (2004) Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 10:S53-S57.
21. Cleveland JC, Raeburn C, Harken AH. (2001) Clinical applications of ischemic preconditioning: From head to toe. Surgery 129:664-667.
22. Raeburn CD, Cleveland JC, Zimmerman MA, Harken AH. (2001) Organ preconditioning. Arch Surg 136:1263-1266.
23. Arai M, Thurman RG, Lemasters JJ. (2001) Ischemic preconditioning of rat livers against cold storage-reperfusion injury: Role of non parenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 7:292-299.
24. Lloris-Carsis JM, Cejalvo D, Toledo-Pereyra LH et al. (1993) Preconditioning: Effect upon lesion modulation in warm liver ischemia. Transplant Proc 25:3303-3304.
25. Kume M, Yamamoto Y, Saad S et al. (1996) Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 128:251-258.
26. Totsuka E, Fung JJ, Urakami A et al. (2000) Influence of donor cardiopulmonary arrest in human liver transplantation: Possible role of ischemic preconditioning. Hepatology 31:577-580.
27. Wilson DJ, Fisher A, Das K et al. (2003) Donors with cardiac arrest: Improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 75:1683-1687.
28. Lee S, Park K, Hwang S et al. (2001) Congestion of right liver graft in living donor liver transplantation. Transplantation 71:812-814. (Pubitemid 32373699)
29. Sugawara Y, Makuuchi M, Sano K et al. (2003) Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg 237:180-185. (Pubitemid 38173244)
30. Calne RY, William R. (1968) Transplantation in man. I Observations on technique and organization in five cases. Br Med J 4:535-540.
31. Belghiti J, Panis Y, Sauvanet A et al. (1992) A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet 175:271-272.
32. Adam R, Reynes M, Johann M et al. (1991) The outcome of steatotic grafts in liver transplantation. Transplant Proc 23:1538-1540.
33. Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. (1979) Accurate measurement of liver, kidney, and spleen volume mass by computerized axial tomography. Ann Intern Med 90:185-187.
34. Henderson JM, Heymsfield SB, Horowitz J, Kutner MH. (1981) Measurement of liver and spleen volume by computed tomography. Radiology 141:525-527.
35. Van Thiel DH, Hagler NG, Schade RR et al. (1985) In vivo hepatic volume determination using sonography and computed tomography. Gastroenterology 88:1812-1817.
36. Demetris A, Batts K, Dhillon A, Wight D, Williams J, Yamabe H. (1997) Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 25:658-663.
37. Miller CH, Masetti M, Cautero N et al. (2004) Intermittent inflow occlusion in living liver donors: Impact on safety and remnant function. Liver Transpl 10:244-247.
38. Testa G, Angelova V, Laricchia-Robbio L et al. (2009) Unilateral ischemic preconditioning and heterologous preconditioning in living donor liver transplantation. Clin Transplant 24:334-340.
39. Park KM, Chen A, Bonventre JV. (2001) Prevention of kidney ischemia/ reperfusion-induced functional injury and JNK, p38, and MARK kinase activation by remote ischemic pretreatment. J Biol Chem 276:1870-1876.
40. Turman MA, Bates CM. (1997) Susceptibility of human proximal tubular cells to hypoxia: Effect of hypoxic preconditioning and comparison to glomerular cells. Ren Fail 19:47-60.
41. Berhends M, Walz MK, Kribben A et al. (2000) No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol 85:819-827.
42. Jefayri MK, Grace PA, Mathie RT. (2000) Attenuation of reperfusion injury by renal ischaemic preconditioning: The role of nitric oxide. BJU Int 85:1007-1013.
43. Arend LJ, Thompson CI, Spielman WS. (1985) Dypiramidol decreases glomerular filtration in the sodium-depleted dog. Evidence for mediation by intrarenal adenosine. Circ Res 56:242-251.
44. Kosieradzki M, Ametani M, Southard JH, Mangino MJ. (2003) Is ischemic preconditioning of the kidney clinically relevant? Surgery 133:81-90.
45. Cochrane J, Williams BT, Banerjee A et al. (1999) Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic renal failure in the rat. Ren Fail 21:135-145.
46. Islam CF, Mathie RT, Dinneen MD et al. (1997) Ischaemia-reperfusion injury in the rat kidney: The effect of preconditioning.Br J Urol 79:842-847.
47. Pagliaro P, Gattullo D, Rastaldo R, Losano G. (2001) Ischemic preconditioning: From the first to the second window of protection. Life Sci 69:1-15.
48. Sakon M, Ariyoshi H, Umeshita K, Monden M. (2002) Ischemiareperfusion injury of the liver with special reference to calcium-dependent mechanisms. Surg Today 32:1-12.
49. Mokuno Y, Berthiaume F, Tompkins RG et al. (2004) Technique for expanding the donor liver pool: Heat shock preconditioning in a rat fatty liver model. Liver Transpl 10:264-272.
50. Glanemann M, Strenziok R, Kuntze R et al. (2004) Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/ reperfusion injury. Surgery 135:203-214.
51. Klein M, Geoghegan J, Wangemann R et al. (1999) Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury. Transplantation 67:1128-1132.
52. Adam R, Arnault I, Bao YM, Salvucci M, Sebagh M, Bismuth H. (1998) Effect of ischemic preconditioning on hepatic tolerance to cold ischemia in the rat. Transpl Int 11:S168-S170.
53. Azoulay D, Del Gaudio M, Andreani P, Ichai P, Sebag M, Adam R et al. (2005) Effects of ten minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: The Ying and the Yang. Ann Surg 242:133-139.
54. Koneru B, Fisher A, He Y et al. (2005) Ischemic preconditioning in deceased donor liver trnsplantation: A prospective randomized clinical trial of safety and efficacy. Liver Transpl 11:196-202.
55. Przyklenk K, Bauer B, Ovize M et al. (1993) Regional 'ischemic preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:893-899.
56. Barrier A, Olaya N, Chappini F et al. (2005) Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemiareperfusion. FASEB J 19:1617